User profiles for A. Moghe

Akshata Moghe

- Verified email at uth.tmc.edu - Cited by 1930

Alpana Moghe

- Verified email at bharatividyapeeth.edu - Cited by 390

Dr. Asmita A. Moghe

- Verified email at rgpv.ac.in - Cited by 156

Co‐axial electrospinning for nanofiber structures: preparation and applications

AK Moghe, BS Gupta - Polymer Reviews, 2008 - Taylor & Francis
<p>Preparation of nanofibers in a core‐sheath configuration, using two dissimilar materials,
via a novel technique of co‐axial electrospinning has presented unusual potential for use in …

Molecular mechanisms of acrolein toxicity: relevance to human disease

A Moghe, S Ghare, B Lamoreau… - Toxicological …, 2015 - academic.oup.com
Acrolein, a highly reactive unsaturated aldehyde, is a ubiquitous environmental pollutant
and its potential as a serious environmental health threat is beginning to be recognized. …

β-catenin activation promotes immune escape and resistance to anti–PD-1 therapy in hepatocellular carcinoma

…, M Dhainaut, C Villacorta-Martin, AD Singhi, A Moghe… - Cancer discovery, 2019 - AACR
Determinants of response to anti–PD-1 immunotherapies in HCC are poorly understood.
Using a novel mouse model of HCC, we show that β-catenin activation promotes immune …

Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study

…, KD Chavin, K Zhou, B Lizaola-Mayo, A Moghe… - Clinical …, 2021 - Elsevier
Background & Aims Chronic liver disease (CLD) represents a major global health burden.
We undertook this study to identify the factors associated with adverse outcomes in patients …

[HTML][HTML] Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients

S Barve, R Kapoor, A Moghe, JA Ramirez… - Alcohol research & …, 2010 - ncbi.nlm.nih.gov
Since the introduction of highly active antiretroviral therapy (HAART) in the 1990s, liver
disease is emerging as a major cause of morbidity and mortality among HIV-infected patients. …

[PDF][PDF] Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by β-catenin mutations

AOA Michael, S Ko, J Tao, A Moghe, H Yang, M Xu… - Cell metabolism, 2019 - cell.com
Based on their lobule location, hepatocytes display differential gene expression, including
pericentral hepatocytes that surround the central vein, which are marked by Wnt-β-catenin …

Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID‐19): US multicenter experience

…, PV Perumalswami, V Nguyen, A Moghe… - …, 2020 - Wiley Online Library
Background and Aims Coronavirus disease 2019 (COVID‐19) is associated with liver injury,
but the prevalence and patterns of liver injury in liver transplantation (LT) recipients with …

Sarcopenia predicts post-transplant mortality in acutely ill men undergoing urgent evaluation and liver transplantation

…, AJ Montano-Loza, EJ Carey, S Lin, A Moghe… - …, 2019 - journals.lww.com
Background. We examined the association between sarcopenia and post-transplant mortality
in acutely ill inpatients with cirrhosis who underwent urgent liver transplantation. Methods. …

[PDF][PDF] β‐Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis

MD Thompson, A Moghe, P Cornuet, R Marino… - …, 2018 - Wiley Online Library
Cholestatic liver diseases result from impaired bile flow and are characterized by inflammation,
atypical ductular proliferation, and fibrosis. The Wnt/β‐catenin pathway plays a role in …

Nuclear factor erythroid 2–related factor 2 and β‐Catenin coactivation in hepatocellular cancer: biological and therapeutic implications

J Tao, Y Krutsenko, A Moghe, S Singh, M Poddar… - …, 2021 - Wiley Online Library
Background and Aims HCC remains a major unmet clinical need. Although activating catenin
beta‐1 (CTNNB1) mutations are observed in prominent subsets of HCC cases, these by …